Bokf Na lessened its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 40.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 84,393 shares of the real estate investment trust's stock after selling 57,585 shares during the period. Bokf Na's holdings in Healthpeak Properties were worth $1,357,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of DOC. Mather Group LLC. bought a new position in Healthpeak Properties in the third quarter valued at $25,000. WPG Advisers LLC lifted its position in Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust's stock worth $26,000 after buying an additional 1,197 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Healthpeak Properties during the 2nd quarter worth about $33,000. Wiser Advisor Group LLC bought a new position in shares of Healthpeak Properties in the 3rd quarter valued at about $38,000. Finally, AlphaQuest LLC grew its holdings in shares of Healthpeak Properties by 49.2% in the 3rd quarter. AlphaQuest LLC now owns 2,864 shares of the real estate investment trust's stock valued at $55,000 after acquiring an additional 944 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Trading Down 0.3%
Shares of DOC stock opened at $19.61 on Friday. The business has a 50-day moving average price of $17.02 and a two-hundred day moving average price of $17.16. The company has a quick ratio of 2.82, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $19.87. The firm has a market cap of $13.52 billion, a P/E ratio of 61.28, a price-to-earnings-growth ratio of 2.72 and a beta of 1.00.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to analysts' expectations of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business's revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.74 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The firm also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 6.2%. Healthpeak Properties's payout ratio is presently 381.25%.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. Morgan Stanley dropped their target price on shares of Healthpeak Properties from $21.00 to $18.00 and set an "overweight" rating on the stock in a report on Tuesday, April 28th. Citigroup lowered their price target on Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating on the stock in a research report on Wednesday, April 1st. Robert W. Baird dropped their price objective on Healthpeak Properties from $20.00 to $19.00 and set an "outperform" rating on the stock in a research note on Monday, April 6th. UBS Group started coverage on Healthpeak Properties in a research note on Monday, April 20th. They set a "neutral" rating and a $17.00 target price for the company. Finally, Argus cut Healthpeak Properties from a "buy" rating to a "hold" rating in a report on Thursday, February 5th. Five research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, Healthpeak Properties currently has an average rating of "Hold" and an average price target of $18.04.
View Our Latest Stock Analysis on Healthpeak Properties
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.